Facioscapulohumeral Dystrophy

Constantine Farmakidis, Rabi Tawil

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is a dominantly inherited disease with a distinctive clinical presentation. It presents initially with facial and scapular weakness, and progresses in a descending fashion to involve the lower extremities. Disease severity is extremely variable, with about 20%, of individuals becoming wheelchair dependent. Although no curative treatment for FSHD exists, recent discoveries of the underlying pathophysiology open the door for the development of targeted treatments.

Original languageEnglish (US)
Title of host publicationNeuromuscular Disorders
PublisherWiley-Blackwell
Pages74-79
Number of pages6
ISBN (Print)0470654562, 9780470654569
DOIs
StatePublished - Sep 6 2011
Externally publishedYes

Fingerprint

Facioscapulohumeral Muscular Dystrophy
Wheelchairs
Lower Extremity

Keywords

  • Conditions mimicking FSHD
  • Creatine kinase (CK) levels
  • Facial and shoulder weakness
  • Facial weakness
  • Facioscapulohumeral dystrophy (FSHD) - autosomal neuromuscular disorder
  • Foot drop
  • FSHD extramuscular manifestations
  • FSHD, broad clinical spectrum of age
  • Mild retinovascular abnormalities
  • Weak abdominal muscles

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Farmakidis, C., & Tawil, R. (2011). Facioscapulohumeral Dystrophy. In Neuromuscular Disorders (pp. 74-79). Wiley-Blackwell. https://doi.org/10.1002/9781119973331.ch9

Facioscapulohumeral Dystrophy. / Farmakidis, Constantine; Tawil, Rabi.

Neuromuscular Disorders. Wiley-Blackwell, 2011. p. 74-79.

Research output: Chapter in Book/Report/Conference proceedingChapter

Farmakidis, C & Tawil, R 2011, Facioscapulohumeral Dystrophy. in Neuromuscular Disorders. Wiley-Blackwell, pp. 74-79. https://doi.org/10.1002/9781119973331.ch9
Farmakidis C, Tawil R. Facioscapulohumeral Dystrophy. In Neuromuscular Disorders. Wiley-Blackwell. 2011. p. 74-79 https://doi.org/10.1002/9781119973331.ch9
Farmakidis, Constantine ; Tawil, Rabi. / Facioscapulohumeral Dystrophy. Neuromuscular Disorders. Wiley-Blackwell, 2011. pp. 74-79
@inbook{21613325aa944723adfe35b67f221fdf,
title = "Facioscapulohumeral Dystrophy",
abstract = "Facioscapulohumeral muscular dystrophy (FSHD) is a dominantly inherited disease with a distinctive clinical presentation. It presents initially with facial and scapular weakness, and progresses in a descending fashion to involve the lower extremities. Disease severity is extremely variable, with about 20{\%}, of individuals becoming wheelchair dependent. Although no curative treatment for FSHD exists, recent discoveries of the underlying pathophysiology open the door for the development of targeted treatments.",
keywords = "Conditions mimicking FSHD, Creatine kinase (CK) levels, Facial and shoulder weakness, Facial weakness, Facioscapulohumeral dystrophy (FSHD) - autosomal neuromuscular disorder, Foot drop, FSHD extramuscular manifestations, FSHD, broad clinical spectrum of age, Mild retinovascular abnormalities, Weak abdominal muscles",
author = "Constantine Farmakidis and Rabi Tawil",
year = "2011",
month = "9",
day = "6",
doi = "10.1002/9781119973331.ch9",
language = "English (US)",
isbn = "0470654562",
pages = "74--79",
booktitle = "Neuromuscular Disorders",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Facioscapulohumeral Dystrophy

AU - Farmakidis, Constantine

AU - Tawil, Rabi

PY - 2011/9/6

Y1 - 2011/9/6

N2 - Facioscapulohumeral muscular dystrophy (FSHD) is a dominantly inherited disease with a distinctive clinical presentation. It presents initially with facial and scapular weakness, and progresses in a descending fashion to involve the lower extremities. Disease severity is extremely variable, with about 20%, of individuals becoming wheelchair dependent. Although no curative treatment for FSHD exists, recent discoveries of the underlying pathophysiology open the door for the development of targeted treatments.

AB - Facioscapulohumeral muscular dystrophy (FSHD) is a dominantly inherited disease with a distinctive clinical presentation. It presents initially with facial and scapular weakness, and progresses in a descending fashion to involve the lower extremities. Disease severity is extremely variable, with about 20%, of individuals becoming wheelchair dependent. Although no curative treatment for FSHD exists, recent discoveries of the underlying pathophysiology open the door for the development of targeted treatments.

KW - Conditions mimicking FSHD

KW - Creatine kinase (CK) levels

KW - Facial and shoulder weakness

KW - Facial weakness

KW - Facioscapulohumeral dystrophy (FSHD) - autosomal neuromuscular disorder

KW - Foot drop

KW - FSHD extramuscular manifestations

KW - FSHD, broad clinical spectrum of age

KW - Mild retinovascular abnormalities

KW - Weak abdominal muscles

UR - http://www.scopus.com/inward/record.url?scp=84885743139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885743139&partnerID=8YFLogxK

U2 - 10.1002/9781119973331.ch9

DO - 10.1002/9781119973331.ch9

M3 - Chapter

AN - SCOPUS:84885743139

SN - 0470654562

SN - 9780470654569

SP - 74

EP - 79

BT - Neuromuscular Disorders

PB - Wiley-Blackwell

ER -